SII、SIRI联合多项炎性因子对AECOPD合并社区获得性肺炎的预后评估

Values of SII and SIRI combined with inflammatory factors in assessment of prognosis of AECOPD patients complicated with community-acquired pneumonia

  • 摘要: 目的 探讨系统免疫炎症指数(SII)、系统炎症反应指数(SIRI)联合多项炎性因子对慢性阻塞性肺疾病急性加重期(AECOPD)合并社区获得性肺炎(CAP)的预后评估价值。方法 选取2021年1月-2024年12月开滦总医院收治的400例AECOPD合并CAP患者为研究对象,根据患者入院治疗2周后预后情况分为好转组192例和恶化组208例。比较两组患者临床资料、SII、SIRI和多项血清炎性因子差异。采用多因素二元logistic回归分析AECOPD合并CAP患者预后的影响因素,使用受试者工作特征(ROC)曲线评价SII、SIRI联合多项血清炎性因子对AECOPD合并CAP的预后评估价值。结果 恶化组患者SII、SIRI及多项炎性因子均高于好转组(P<0.05)。年龄、病程、合并其他疾病种类、1年内COPD加重次数、COPD和哮喘生理(CAPS)评分和CURB-65评分是AECOPD合并CAP患者预后的危险因素(P<0.05),GOLD肺功能分级、25-羟基维生素D(25OHD)是保护因素(P<0.05)。SII、SIRI对AECOPD合并CAP患者预后评估价值的曲线下面积(AUC)分别为0.803、0.848,SII、SIRI联合多项炎性因子的AUC为0.963,高于单独检测(P<0.05)。结论 AECOPD合并CAP患者SII、SIRI处于较高水平,二者可作为评估AECOPD合并CAP患者预后的生物学指标,且联合其他炎性因子可提高AECOPD合并CAP患者预后评估价值。

     

    Abstract: OBJECTIVE To explore the values of systemic immune-inflammation index (SII) and systemic inflammation response index (SIRI) combined with multiple inflammatory factors in assessment of prognosis of the acute exacerbation of chronic obstructive pulmonary disease (AECOPD) patients complicated with community-acquired pneumonia (CAP). METHODS A total of 400 AECOPD patients who were complicated with CAP and treated in Kailuan General Hospital from Jan. 2021 to Dec. 2024 were recruited as the research subjects and were divided into the improvement group with 192 cases and the exacerbation group with 208 cases according to the treatment outcomes 2 weeks after the admission to the hospital. The clinical data, SII, SIRI, and serum inflammatory factors were compared between the two groups of patients. Multivariate binary logistic regression analysis was performed for the influencing factors for the prognosis of the AECOPD patients complicated with CAP. The values of SII and SIRI combined with the serum inflammatory factors in assessment of the prognosis of the AECOPD patients complicated with CAP were evaluated by using receiver operating characteristics (ROC)curves. RESULTS The levels of SII, SIRI and multiple inflammatory factors of the exacerbation group were higher than those of the improvement group (P<0.05). The age, course of disease, complication with other types of diseases, number of times of exacerbation of COPD within 1 year, COPD and asthma physiology score (CAPS), and CURB-65 score were the risk factors for the prognosis of the AECOPD patients complicated with CAP (P<0.05), while the GOLD lung function classification and 25-hydroxyvitamin D (25OHD) were the protective factors (P<0.05). The areas under the curves (AUCs) of SII and SIRI in assessment of the prognosis of the AECOPD patients complicated with CAP were 0.803 and 0.848, respectively, and the AUC of SII and SIRI combined with multiple inflammatory factors was 0.963, higher than that of the single indicator (P<0.05). CONCLUSIONS The AECOPD patients complicated with CAP show high levels of SII and SIRI, and the two indicators can be used as biological indicators for assessment of the prognosis of the patients. The combination with other inflammatory factors may raise the value in assessment of the prognosis of the AECOPD patients complicated with CAP.

     

/

返回文章
返回